Evidence map›Paper›PMID 24816718›Full record

ArticlePloS one2014

Integration of molecular profiling and chemical imaging to elucidate fibroblast-microenvironment impact on cancer cell phenotype and endocrine resistance in breast cancer.

Sarah E Holton, Anna Bergamaschi, Benita S Katzenellenbogen, Rohit Bhargava

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Targeting the tumour stroma to improve cancer therapy.Nature reviews. Clinical oncology · 2018
    Review
  10. Review
  11. Infrared spectroscopic imaging: Label-free biochemical analysis of stroma and tissue fibrosis.The international journal of biochemistry & cell biology · 2017
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sarah E HoltonDepartment of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America; Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America.
Anna BergamaschiDepartments of Molecular and Integrative Physiology, Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America.
Benita S KatzenellenbogenDepartments of Molecular and Integrative Physiology, Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America; University of Illinois Cancer Center, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America.
Rohit BhargavaDepartment of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America; Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America; University of Illinois Cancer Center, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America; Departments of Mechanical Science and Engineering, Electrical and Computer Engineering, and Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America.
University of Illinois Urbana-Champaign · US

Funding

Discrete Frequency Infrared Spectroscopic Imaging for Breast HistopathologyR01EB009745 · NIBIB · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI BHARGAVA, ROHIT · 2010 to 2025
$5.1M
Infrared microscopy for a systems approach to prostate pathologyR01CA138882 · NCI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI BHARGAVA, ROHIT · 2010 to 2014
$1.5M
NCI NIH HHS R01 CA138882NCI NIH HHS R01CA138882NIBIB NIH HHS R01 EB009745NIBIB NIH HHS R01EB009745
6 · The paper itself

Abstract

The tumor microenvironment is known to play a key role in altering the properties and behavior of nearby cancer cells. Its influence on resistance to endocrine therapy and cancer relapse, however, is poorly understood. Here we investigate the interaction of mammary fibroblasts and estrogen receptor-positive breast cancer cells in three-dimensional culture models in order to characterize gene expression, cellular changes, and the secreted protein factors involved in the cellular cross-talk. We show that fibroblasts, which are the predominant cell type found in the stroma adjacent to the cancer cells in a tumor, induce an epithelial-to-mesenchymal transition in the cancer cells, leading to hormone-independent growth, a more invasive phenotype, and resistance to endocrine therapy. Here, we applied a label-free chemical imaging modality, Fourier transform infrared (FT-IR) spectroscopic imaging, to identify cells that had transitioned to hormone-independent growth. Both the molecular and chemical profiles identified here were translated from cell culture to patient samples: a secreted protein signature was used to stratify patient populations based on gene expression and FT-IR was used to characterize breast tumor patient biopsies. Our findings underscore the role of mammary fibroblasts in promoting aggressiveness and endocrine therapy resistance in ER-positive breast cancers and highlight the utility of FT-IR for the further characterization of breast cancer samples.

Indexed as

Drug Resistance, NeoplasmMolecular ImagingPhenotypeTumor MicroenvironmentBreast NeoplasmsCell CommunicationCoculture TechniquesDown-RegulationEpithelial-Mesenchymal TransitionEstrogen Receptor alphaFibroblastsHormonesHumansMammary Glands, HumanMCF-7 CellsPrognosisEstrogen Receptor alphaHormones

Identifiers

PMID24816718
PMCPMC4016150
OpenAlexW1989360915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.